Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry. (Record no. 26623996)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02113 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517124756.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1029-2403 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1080/10428194.2016.1256481 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bartlett, Nancy L |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180112 |
| 245 00 - TITLE STATEMENT | |
| Title | Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Leukemia & lymphoma |
| Date of publication, distribution, etc. | 07 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1607-1616 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Immunological |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Brentuximab Vedotin |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunoconjugates |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunohistochemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ki-1 Antigen |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphoma, Large B-Cell, Diffuse |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recurrence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retreatment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smith, Mitchell R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Siddiqi, Tanya |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Advani, Ranjana H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Connor, Owen A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sharman, Jeff P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Feldman, Tatyana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Savage, Kerry J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shustov, Andrei R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Diefenbach, Catherine S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oki, Yasuhiro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Palanca-Wessels, Maria Corinna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Uttarwar, Mayur |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Martha |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yang, Jing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jacobsen, Eric D |
| 773 0# - HOST ITEM ENTRY | |
| Title | Leukemia & lymphoma |
| Related parts | vol. 58 |
| -- | no. 7 |
| -- | p. 1607-1616 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1080/10428194.2016.1256481">https://doi.org/10.1080/10428194.2016.1256481</a> |
| Public note | Available from publisher's website |
No items available.